ECM2 and leiomyoma: Since the expression of E2F1, RUNX3, EGR3, TBPIP, ECM-2, ESM1, THBS1, GAS1, ADAM17, CST6, FBLN5, and COL18A1 was evaluated in leiomyomas using LDA-based realtime PCR as described in the accompanying manuscript [17] we used the same approach and compared their expression in keloids, incisional scars and peritoneal adhesions.